Middle East and Africa omega-3 ingredients for pharmaceuticals market is projected to register a healthy CAGR of 8.4% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.
Market Segmentation:
Middle East and Africa Omega-3 Ingredients for Pharmaceuticals Market, By Source (Marine and Plant), Type (Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid (EPA) and Alpha-Linolenic Acid (ALA)), Form (Liquid and Dry), Therapeutic Areas (Cardiovascular Diseases, Autoimmune Diseases, Bone & Joint Disorders, Neurological Disorders, Ophthalmic Disorders, Skin Health, Cancer and Others), Population Type (Adults and Children), Distribution Channel (Direct and Indirect), Country (South Africa, Saudi Arabia, U.A.E., Kuwait and Rest of Middle East and Africa) Industry Trends & Forecast to 2027

Some of the major factors contributing to the growth of Middle East and Africa omega-3 ingredients for pharmaceuticals market are:

- Growing demand of functional and supplement food
- Rising burden of lifestyle diseases leads the demand of Omega-3 based products
Market Players:

The key market players for Middle East and Africa omega-3 ingredients for pharmaceuticals market are listed below:

- AbbVie Inc.
- BASF SE
- Corbion NV
- DSM
- AstraZeneca
- GlaxoSmithKline plc.
- Strides Pharma Science Limited